Skip to main content
. 2019 Apr 1;10:2040620719839025. doi: 10.1177/2040620719839025

Table 2.

Per-patient-per-month all-cause healthcare utilization over the entire follow-up period.

Entire follow-up period
PN cases
Non-PN
controls
p value
n = 1387 n = 2594
All-cause healthcare utilization (PPPM)
Patients with an inpatient admission, % 77.4% 67.2% <0.001
Admissions PPPM, mean (SD) 0.11 (0.14) 0.10 (0.15) 0.019
 Patients with an admission, mean (SD) 0.14 (0.14) 0.15 (0.16) 0.373
Patients with an ER visit, % 67.8% 58.4% <0.001
ER visits PPPM, mean (SD) 0.13 (0.33) 0.11 (0.22) 0.015
 Patients with a visit, mean (SD) 0.19 (0.39) 0.19 (0.26) 0.629
Patients with an outpatient office visit, N% 97.9% 96.6% 0.024
Outpatient office visits PPPM, mean (SD) 1.7 (1.2) 1.6 (1.2) 0.142
 Patients with a visit, mean (SD) 1.7 (1.2) 1.7 (1.1) 0.342
Patients with outpatient hospital-based visits, % 98.7% 96.3% <0.001
Outpatient hospital-based visits PPPM, mean (SD) 13.3 (14.7) 11.1 (17.8) <0.001
 Patients with a visit, mean (SD) 13.5 (14.7) 11.5 (18.0) <0.001
Patients with a laboratory test, % 90.9% 87.9% 0.003
Laboratory tests PPPM, mean (SD) 3.7 (5.0) 4.1 (5.5) 0.018
 Patients with a test, mean (SD) 4.1 (5.0) 4.7 (5.6) 0.001
Patients filling an outpatient prescription, % 97.2% 97.1% 0.941
Outpatient prescriptions PPPM, mean (SD) 4.6 (2.6) 4.0 (2.5) <0.001
 Patients with a prescription, mean (SD) 4.7 (2.5) 4.2 (2.4) <0.001

ER, emergency department (room); PN, peripheral neuropathy; PPPM, per patient per month; SD, standard deviation.